Advertisement

Annals of Surgical Oncology

, Volume 18, Issue 3, pp 832–837 | Cite as

Correlation Between gp96 Expression and the Surgical Outcome in Patients With Esophageal Squamous Cell Carcinoma

  • Yasunori Akutsu
  • Hisahiro Matsubara
  • Masayuki Kano
  • Akihiro Usui
  • Yasuo Yoneyama
  • Norimasa Ikeda
  • Aki Komatsu
  • Gulbostan Yusup
Thoracic Oncology

Abstract

Background

Heat-shock protein gp96 plays an important role in antitumor immunoreactions. Gp96 has a close relationship with antitumor immunity. This study evaluated the correlation between gp96 expression and the prognosis in esophageal squamous cell carcinoma.

Methods

Seventy-eight patients with primarily resected esophageal squamous cell carcinoma were enrolled onto this study, and gp96 expression was evaluated by immunohistochemical staining. The association of clinicopathological factors and patients’ survival was calculated by univariate (log rank test) and multivariate (Cox proportional hazard regression method) analyses.

Results

Fifty-seven (73%) of 78 cases were gp96 positive, and 21 were negative (27%). The survival of patients with gp96-negative disease was significantly shorter (5-year survival, 22.9 months) than with gp96-positive disease (45.8 months; P = 0.049), and the multivariate analysis showed that gp96 negativity is an independent risk factor for poor survival (hazard ratio, 2.577; P = 0.040). Gp96-negative cases had more metastatic lymph nodes than did negative cases, especially in T1 cases (4.8 in gp96-negative cases vs. 0.84 in gp96-positive cases; P = 0.064)

Conclusions

The downregulation of gp96 expression is closely correlated with poor survival in esophageal squamous cell carcinoma.

Keywords

Esophageal Cancer Esophageal Squamous Cell Carcinoma Metastatic Lymph Node Antitumor Immunity Esophageal Squamous Cell Carcinoma Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgment

This research was supported by a Grant-in-Aid for Young Scientists (B) 21791268, the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors declare that they have no conflicts of interest.

References

  1. 1.
    Strbo N, Pahwa S, Kolber MA, et al. Cell-secreted Gp96-Ig-peptide complexes induce lamina propria and intraepithelial CD8(+) cytotoxic T lymphocytes in the intestinal mucosa. Mucosal Immunol. 2010;3:182–92.PubMedCrossRefGoogle Scholar
  2. 2.
    Ramirez SR, Singh-Jasuja H, Warger T, et al. Glycoprotein 96-activated dendritic cells induce a CD8-biased T cell response. Cell Stress Chaperones. 2005;10:221–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Srivastava PK, Udono H. Heat shock protein-peptide complexes in cancer immunotherapy. Curr Opin Immunol. 1994;6:728–32.PubMedCrossRefGoogle Scholar
  4. 4.
    Basu S, Binder RJ, Ramalingam T, Srivastava PK. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity. 2001;14:303–13.PubMedCrossRefGoogle Scholar
  5. 5.
    Binder RJ, Srivastava PK. Essential role of CD91 in re-presentation of gp96-chaperoned peptides. Proc Natl Acad Sci USA. 2004;101:6128–33.PubMedCrossRefGoogle Scholar
  6. 6.
    Akutsu Y, Matsubara H, Shuto K, et al. Clinical and pathologic evaluation of the effectiveness of neoadjuvant chemoradiation therapy in advanced esophageal cancer patients. World J Surg. 2009;33:1002–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Matsubara H. Neoadjuvant chemoradiation therapy for the treatment of esophageal carcinoma. Int J Clin Oncol. 2008;13:474–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Akutsu Y, Matsubara H, Shuto K, et al. Pre-operative dental brushing can reduce the risk of postoperative pneumonia in esophageal cancer patients. Surgery. 2010;147:497–502.PubMedCrossRefGoogle Scholar
  9. 9.
    Akutsu Y, Matsubara H. Perioperative management for the prevention of postoperative pneumonia with esophageal surgery. Ann Thorac Cardiovasc Surg. 2009;15:280–5.PubMedGoogle Scholar
  10. 10.
    Akutsu Y, Matsubara H, Urashima T, et al. Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice. Int J Oncol. 2007;31:509–15.PubMedGoogle Scholar
  11. 11.
    Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology. 1991;48:411–20.PubMedCrossRefGoogle Scholar
  12. 12.
    Baker-LePain JC, Sarzotti M, Fields TA, Li CY, Nicchitta CV. GRP94 (gp96) and GRP94N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression. J Exp Med. 2002;196:1447–59.PubMedCrossRefGoogle Scholar
  13. 13.
    Shinagawa N, Yamazaki K, Tamura Y, et al. Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells. Cancer Immunol Immunother. 2008;57:165–74.PubMedCrossRefGoogle Scholar
  14. 14.
    Graner MW, Zeng Y, Feng H, Katsanis E. Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers. Cancer Immunol Immunother. 2003;52:226–34.PubMedGoogle Scholar
  15. 15.
    Hoshino I, Matsubara H, Akutsu Y, et al. Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients. Oncol Rep. 2007;18:867–71.PubMedGoogle Scholar
  16. 16.
    Nishimori T, Tomonaga T, Matsushita K, et al. Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin. Proteomics. 2006;6:1011–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Tohma T, Okazumi S, Makino H, et al. Overexpression of glucose transporter 1 in esophageal squamous cell carcinomas: a marker for poor prognosis. Dis Esophagus. 2005;18:185–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Kaneko K, Kumekawa Y, Makino R, et al. EGFR gene alterations as a prognostic biomarker in advanced esophageal squamous cell carcinoma. Front Biosci. 2010;15:65–72.PubMedCrossRefGoogle Scholar
  19. 19.
    Wang F, Wang Y, Yu X, et al. Significance of Jab1 expression in human esophageal squamous cell carcinoma. J Clin Gastroenterol. 2009;43:520–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Strauss L, Bergmann C, Gooding W, Johnson JT, Whiteside TL. The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clin Cancer Res. 2007;13:6301–11.PubMedCrossRefGoogle Scholar
  21. 21.
    Kliger Y, Levy O, Oren A, et al. Peptides modulating conformational changes in secreted chaperones: from in silico design to preclinical proof of concept. Proc Natl Acad Sci USA. 2009;106:13797–801.PubMedCrossRefGoogle Scholar
  22. 22.
    Huang QQ, Sobkoviak R, Jockheck-Clark AR, et al. Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. J Immunol. 2009;182:4965–73.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2010

Authors and Affiliations

  • Yasunori Akutsu
    • 1
  • Hisahiro Matsubara
    • 1
  • Masayuki Kano
    • 1
  • Akihiro Usui
    • 1
  • Yasuo Yoneyama
    • 1
  • Norimasa Ikeda
    • 1
  • Aki Komatsu
    • 1
  • Gulbostan Yusup
    • 1
  1. 1.Department of Frontier Surgery, Graduate School of MedicineChiba UniversityChibaJapan

Personalised recommendations